Metabolic-Fit / 100
TeleClinic review
TeleClinic's whole pitch is a promise called Price-Lock: "The price you start with is the price you keep." Printed directly above that sentence is a table reading "Intro rate (first quarter) $139/mo · Standard rate $199/mo." Both cannot be true. Read the feature list underneath and the lock turns out to be about dose — titrate up without paying more — not about the introductory rate, which does expire. The $79 first month for semaglutide is real, the flat-across-doses pricing is real, and 47 states is a wide footprint. Just do not read "locked from day one" as a promise about $79.
then $199/mo ongoing
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
TeleClinic at a glance
- Semaglutide
- $199/mo standard rate, not broken out by drug
- Tirzepatide
- $199/mo standard rate, not broken out by drug
- Coverage
- 47 states — not California, South Carolina or New Jersey
- Brand-name
- Compounded only
How we scored TeleClinic
Every factor comes from TeleClinic's own published pricing, disclosures and oversight, and the six combine into the 38/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Cost is unpredictable or sits at the premium end.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Support is thin once the prescription ships.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- tele.clinic
Read from TeleClinic's own pages in August 2026. Compounded semaglutide starts at $79 for the first month, or $179 for the first three; tirzepatide is $149 and $399. The site's homepage shows an intro rate of $139 a month becoming a standard rate of $199 — while the same page, and the treatment pages, promise that "the price you start with is the price you keep". Those claims conflict, and the $199 standard rate is never attributed to a particular drug. Price does not rise with dose, TeleClinic serves 47 states (not California, South Carolina or New Jersey), and names Rush Pharmacy as its 503A compounding partner.
What to expect when you sign up
We walked TeleClinic's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1The signup call to action stays on tele.clinic (https://tele.clinic/#treatments)
What we noticed
- A monthly price is visible on the public homepage before any intake — you do not have to hand over information to see a number
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $79 → $199 | Standard rate (not stated per drug)"1st Month Intro $79 — No commitment." The $199 standard rate comes from a homepage table that does not say which drug it applies to. |
| Compounded semaglutide | $59.67 | First three months, prepaid"Or $179 total for first 3 months" — $59.67 a month, charged as one payment. |
| Compounded tirzepatide | $149 → $199 | Standard rate (not stated per drug)"1st Month Intro $149 — No commitment." Same unattributed $199 standard rate. |
| Compounded tirzepatide | $133 | First three months, prepaid"Or $399 total for first 3 months" — $133 a month, charged as one payment. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what TeleClinic's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Price genuinely does not scale with dose — "Same price at every dose" and "Dose increases, price stays the same" — which is the difference that matters most once you titrate up
- Publishes a full state list: 47 states, with California, South Carolina and New Jersey named as the exclusions rather than left to be discovered at checkout
- Names its compounding pharmacy, Rush Pharmacy, and describes it as 503A licensed
- "Not prescribed? You're not charged" — and the refund policy backs it, promising a refund within five business days if a charge was taken first
- Refund policy is unusually specific about damaged shipments, broken cold chain and pharmacy error
The caveats
- The site contradicts itself on its central promise: the treatment pages say "Intro pricing — your rate is locked for the life of your membership" while the homepage table shows an intro rate of $139/mo becoming a standard rate of $199/mo
- "No hidden fees" and "Price includes everything: consultation, medication, shipping" sit alongside a refund policy stating that if your state requires a separate physician consultation fee, it is non-refundable — so a separate consult fee can exist
- The $199 standard rate is never attributed to a specific drug, so there is no published ongoing price for semaglutide or tirzepatide individually
- The $79 and $149 figures are first-month intro rates; the three-month options are prepaid totals
- Weight-loss percentages from the branded drugs' trials — 15% for semaglutide, 20 to 22% for tirzepatide — are presented on pages selling compounded versions that were never in those trials
- Two different support phone numbers appear on the site
TeleClinic for mothers: our verdict
TeleClinic's whole pitch is a promise called Price-Lock: "The price you start with is the price you keep." Printed directly above that sentence is a table reading "Intro rate (first quarter) $139/mo · Standard rate $199/mo." Both cannot be true. Read the feature list underneath and the lock turns out to be about dose — titrate up without paying more — not about the introductory rate, which does expire. The $79 first month for semaglutide is real, the flat-across-doses pricing is real, and 47 states is a wide footprint. Just do not read "locked from day one" as a promise about $79. The advertised entry is $79, but the standing rate settles near $199/month — so read the headline as a starting offer, not the monthly cost.
We weigh TeleClinic the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.
What TeleClinic costs, in full
- Compounded semaglutide — Standard rate (not stated per drug): $79 to start, then $199/mo
- Compounded semaglutide — First three months, prepaid: $59.67/mo
- Compounded tirzepatide — Standard rate (not stated per drug): $149 to start, then $199/mo
- Compounded tirzepatide — First three months, prepaid: $133/mo
That lands within a few dollars of the ~$179/month median across the providers we track, so the monthly cost isn't what should decide this one either way. Weigh it instead on postpartum and breastfeeding timing and PCOS and insulin resistance, and on what the price actually includes — a lower number that leaves out labs, visits or shipping is not the cheaper option.
TeleClinic says the price covers the provider visit, the medication and shipping. That is the comparison that matters at this price: two providers a few dollars apart can differ by a hundred a month once the extras are counted, so line up what each one bundles before you decide.
The medications TeleClinic prescribes
TeleClinic prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where TeleClinic fits — and where it doesn't — for mothers
A good fit if…
- switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.
Oversight, safety, and what we could verify
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
TeleClinic is a reasonable option — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Someone who wants dose-proof pricing and has understood that the intro rate is not the locked one.
Alternatives to TeleClinic
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing TeleClinic
Head-to-head & alternatives
TeleClinic, answered
- How much does TeleClinic cost?
- At last review, TeleClinic's lowest ongoing compounded rate was about $199 a month — $199/mo standard rate, not broken out by drug for semaglutide, $199/mo standard rate, not broken out by drug for tirzepatide. This market re-prices often, so check the current all-in figure at the source before committing.
- Is TeleClinic safe to use while breastfeeding?
- Nothing in this class — compounded or brand — has been established as safe in pregnancy or lactation, and every label advises against use. TeleClinic is not an exception to that. Plan a GLP-1 for after weaning and settle the timing with your own clinician.
- Does TeleClinic offer both semaglutide and tirzepatide?
- Yes — TeleClinic offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does TeleClinic rank for mothers?
- TeleClinic scores 38/100 on our Metabolic-Fit Score and sits at #217. That score is a weighted read of six things mothers actually have to care about. CoreAge Rx currently leads it — see how they compare.
Pricing, states and verification reflect TeleClinic's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.